Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA)
ENTA Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-10.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
66.50%
ENTA Stock Analysis
ENTA
PE Ratio:
ENTA
PEG Ratio:
Not Available
ENTA
Forward EPS Growth (12 month):
0.00%
ENTA
PS Ratio:
3.8
ENTA
PSG Ratio:
-0.5
ENTA
Forward Revenue Growth (12 month):
-7.30%
ENTA Articles
No data was found